Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Dong-sheng Chen"'
Autor:
Tian-mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-jie Tao, Xi-yun Chen, Qin Han, Zhuo Cheng, Pei-pei Shang, Yu-long Dong, He-ming Xu, Lie-ping Guo, Dong-sheng Chen, Yun-jie Song, Chuang Qi, Wang-long Deng, Zhen-gang Yuan
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Chemotherapeutic agents and immune checkpoint inhibitors have shown modest efficacy in patients with advanced biliary tract cancers (BTCs). Here the authors report the results of a phase II trial of the anti-PD1 antibody sintilimab plus chemotherapy
Externí odkaz:
https://doaj.org/article/d415053482214586a39189c889eaa07f
Publikováno v:
水下无人系统学报, Vol 30, Iss 6, Pp 761-767 (2022)
Mobile underwater acoustic communication channels have the typical characteristics of multipath and Doppler dual expansion, which seriously affects communication performance. In particular, the equipment of small underwater unmanned platforms in the
Externí odkaz:
https://doaj.org/article/de01eeacf8094c509988f80af0088285
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundImmune checkpoint inhibitor (ICI)-combined chemotherapy in advanced intrahepatic cholangiocarcinoma has been proved to have more efficacy in a series of clinical trials. However, whether the tumor microenvironment (TME) plays a vital role i
Externí odkaz:
https://doaj.org/article/e52056d2b5c64b8d993d0d7e811b42ce
Autor:
Xiao-yang Gong, Hai-bin Chen, Li-qing Zhang, Dong-sheng Chen, Wang Li, Dong-hui Chen, Jin Xu, Han Zhou, Le-le Zhao, Yun-jie Song, Ming-zhe Xiao, Wang-long Deng, Chuang Qi, Xue-rong Wang, Xi Chen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundPatients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear.MethodsA total of 52 T1-2N0 laryngeal
Externí odkaz:
https://doaj.org/article/6ba630dd5c504c1ea8ba532fa07f7aac
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Novel adjuvant strategies are needed to optimize outcomes after complete surgical resection in patients with early-stage non-small-cell lung cancer (NSCLC). The adjuvant treatment of ROS Proto-Oncogene 1 (ROS1) fusion-positive resected NSCLC is chall
Externí odkaz:
https://doaj.org/article/1edd8d77d09b40fdad59a45edff5b622
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Niraparib, an oral, potent, highly selective poly (ADP-ribose) polymerase (PARP) inhibitor, has promising clinical benefit for maintenance treatment of patients with ovarian cancer in partial response to platinum-based chemotherapy, especially in pat
Externí odkaz:
https://doaj.org/article/2daba9cc243046b8b69208928002358d
Publikováno v:
Journal of Heterocyclic Chemistry. 60:636-644
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b87450dc8634bc7beda4c39f2a58ac9
https://doi.org/10.1002/jhet.4618
https://doi.org/10.1002/jhet.4618
Autor:
Fei Yang, Jun-Jie Jing, Si-Yin Fu, Xiu-Zhu Su, Yu-Ling Zhong, Dong-Sheng Chen, Xiao-Zhi Wu, Yi-Qing Zou
Publikováno v:
Molecular Neurobiology. 60:2086-2098
Central post-stroke pain (CPSP) is a highly refractory form of central neuropathic pain that has been poorly studied mechanistically. Recent observations have emphasized the critical role of the spinal dorsal horn in CPSP. However, the underlying mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cfd05f0bc4362ab34a42641c8b7e251
https://doi.org/10.1007/s12035-022-03184-9
https://doi.org/10.1007/s12035-022-03184-9
Publikováno v:
Investigational New Drugs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf636e0c5baea1712693f8aa7516fbde
https://doi.org/10.1007/s10637-023-01365-4
https://doi.org/10.1007/s10637-023-01365-4
Autor:
Jun-Wei Zhao, Fang Fang, Yi Guo, Tai-Lin Zhu, Yun-Yun Yu, Fan-Fei Kong, Ling-Fei Han, Dong-Sheng Chen, Fang Li
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 35, Iss 1, Pp 1-14 (2016)
Abstract Background The integration of human papilloma virus (HPV) into host genome is one of the critical steps that lead to the progression of precancerous lesion into cancer. However, the mechanisms and consequences of such integration events are
Externí odkaz:
https://doaj.org/article/aa8a7fd2af8e4b5ca6f5bb22c25fc53e